ImmunoPrecise Antibodies
IPA
#9461
Rank
NZ$28.83 M
Marketcap
$1.03
Share price
-0.93%
Change (1 day)
-64.82%
Change (1 year)

ImmunoPrecise Antibodies (IPA) - Total liabilities

Total liabilities on the balance sheet as of July 2024 : NZ$31.51 M

According to ImmunoPrecise Antibodies's latest financial reports the company's total liabilities are NZ$31.51 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

ImmunoPrecise Antibodies - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-04-30NZ$23.69 M7.14%
2022-04-30NZ$22.11 M94.08%
2021-04-30NZ$11.39 M-20.02%
2020-04-30NZ$14.24 M22.75%
2019-04-30NZ$11.6 M-11.6%
2018-04-30NZ$13.13 M1371.7%
2017-04-30NZ$0.89 M65.63%
2016-04-30NZ$0.53 M
2015-12-31NZ$0.26 M-3.75%
2014-12-31NZ$0.27 M-19.43%
2013-12-31NZ$0.34 M6.85%
2012-12-31NZ$0.32 M21.11%
2011-12-31NZ$0.26 M87.34%
2010-12-31NZ$0.14 M11.2%
2009-12-31NZ$0.12 M-39.79%
2008-12-31NZ$0.21 M332.77%
2007-12-31NZ$0.04 M-90.2%
2006-12-31NZ$0.5 M189.52%
2005-12-31NZ$0.17 M187.49%
2004-12-31NZ$0.06 M3.43%
2003-12-31NZ$0.05 M63.97%
2002-12-31NZ$0.03 M-87.41%
2001-12-31NZ$0.28 M